High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1619-7089
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics ; day:5 ; month:7 ; year:2021 ; pages:1-5
European journal of nuclear medicine and molecular imaging ; (5.7.2021), 1-5

Creator
Kesch, Claudia
Yirga, Leubet
Dendl, Katharina
Handke, Analena
Darr, Christopher
Krafft, Ulrich
Radtke, Jan Philipp
Tschirdewahn, Stephan
Szarvas, Tibor
Fazli, Ladan
Gleave, Martin
Giesel, Frederik L.
Haberkorn, Uwe
Hadaschik, Boris
Contributor
SpringerLink (Online service)

DOI
10.1007/s00259-021-05423-y
URN
urn:nbn:de:101:1-2021102521444030058880
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Kesch, Claudia
  • Yirga, Leubet
  • Dendl, Katharina
  • Handke, Analena
  • Darr, Christopher
  • Krafft, Ulrich
  • Radtke, Jan Philipp
  • Tschirdewahn, Stephan
  • Szarvas, Tibor
  • Fazli, Ladan
  • Gleave, Martin
  • Giesel, Frederik L.
  • Haberkorn, Uwe
  • Hadaschik, Boris
  • SpringerLink (Online service)

Other Objects (12)

Targeting molecular resistance in castration-resistant prostate cancer

Targeting molecular resistance in castration-resistant prostate cancer

Evolving Personalized Therapy for Castration-Resistant Prostate Cancer

Evolving Personalized Therapy for Castration-Resistant Prostate Cancer

Osteoclasts directly influence castration-resistant prostate cancer cells

Osteoclasts directly influence castration-resistant prostate cancer cells

Effect of simvastatin on castration-resistant prostate cancer cells

Effect of simvastatin on castration-resistant prostate cancer cells

Ureter metastatic castration-resistant prostate cancer: a case report

Ureter metastatic castration-resistant prostate cancer: a case report

Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends

Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends

Physician preferences for non-metastatic castration-resistant prostate cancer treatment

Physician preferences for non-metastatic castration-resistant prostate cancer treatment

Ailanthone: a new potential drug for castration-resistant prostate cancer

Ailanthone: a new potential drug for castration-resistant prostate cancer

Chromogranin A: a useful biomarker in castration-resistant prostate cancer

Chromogranin A: a useful biomarker in castration-resistant prostate cancer

Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches

Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches

Targeting the adaptive molecular landscape of castration‐resistant prostate cancer

Targeting the adaptive molecular landscape of castration‐resistant prostate cancer

Identification of castration-dependent and -independent driver genes and pathways in castration-resistant prostate cancer (CRPC)

Identification of castration-dependent and -independent driver genes and pathways in castration-resistant prostate cancer (CRPC)

Related objects